Comparison of the oncolytic activity of a replication‐competent and a replication‐deficient herpes simplex virus 1
Immunology · 2024
DOI: 10.1111/imm.13775 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Immunology, 2024. Verfasst von Georg Lindner und 22 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Virus Replication, Oncolytic Virotherapy, Oncolytic Viruses. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
In 2015, the oncolytic herpes simplex virus 1 (HSV‐1) T‐VEC (talimogene laherparepvec) was approved for intratumoral injection in non‐resectable malignant melanoma. To determine whether viral replication is required for oncolytic activity, we compared replication‐deficient HSV‐1 d 106S with replication‐competent T‐VEC. High infectious doses of HSV‐1 d 106S killed melanoma ( n = 10), head‐and‐neck squamous cell carcinoma ( n = 11), and chondrosarcoma cell lines ( n = 2) significantly faster than T‐VEC as measured by MTT metabolic activity, while low doses of T‐VEC were more effective over time. HSV‐1 d 106S and, to a lesser extent T‐VEC, triggered caspase‐dependent early apoptosis as shown by pan‐caspase inhibition and specific induction of caspases 3/7, 8, and 9. HSV‐1 d 106S induced a higher ratio of apoptosis‐inducing infected cell protein (ICP) 0 to apoptosis‐blocking ICP6 than T‐VEC. T‐VEC was oncolytic for an extended period of time as viral replication continued, which could be partially blocked by the antiviral drug aciclovir. High doses of T‐VEC, but not HSV‐1 d 106S, increased interferon‐β mRNA as part of the intrinsic immune response. When markers of immunogenic cell death were assessed, ATP was released more efficiently in the context of T‐VEC than HSV‐1 d 106S infection, whereas HMGB1 was induced comparatively well. Overall, the early oncolytic effect on three different tumour entities was stronger with the non‐replicative strain, while the replication‐competent virus elicited a stronger innate immune response and more pronounced immunogenic cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
- Department of Microbiology - Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
- Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
ORCID-Profile: Barbara Schmidt
Förderung
- NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- Universität Regensburg
- National Institutes of Health
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Lindner, G., Walter, A., Magnus, C. L., Rosenhammer, K., Holoborodko, B., Koch, V., Hirsch, S., Grossmann, L., Li, S., Knipe, D. M., DeLuca, N., Schuler-Thurner, B., Gross, S., Schwertner, B., Toelge, M., Rohrhofer, A., Stöckl, S., Bauer, R. J., Knoll, G., …, & Schuster, P. (2024). Comparison of the oncolytic activity of a replication‐competent and a replication‐deficient herpes simplex virus 1. Immunology. https://doi.org/10.1111/imm.13775
Vancouver
Lindner G, Walter A, Magnus CL, Rosenhammer K, Holoborodko B, Koch V, et al. Comparison of the oncolytic activity of a replication‐competent and a replication‐deficient herpes simplex virus 1. Immunology. 2024. doi:10.1111/imm.13775
BibTeX
@article{Lindner2024,
author = {Lindner, Georg and Walter, Annika and Magnus, Clara L and Rosenhammer, Katharina and Holoborodko, Bohdan and Koch, Victoria and Hirsch, Sarah and Grossmann, Luis and Li, Suqi and Knipe, David M and DeLuca, Neal and Schuler-Thurner, Beatrice and Gross, Stefanie and Schwertner, Barbara and Toelge, Martina and Rohrhofer, Anette and Stöckl, Sabine and Bauer, Richard J and Knoll, Gertrud and Ehrenschwender, Martin and Haferkamp, Sebastian and Schmidt, Barbara and Schuster, Philipp},
title = {Comparison of the oncolytic activity of a replication‐competent and a replication‐deficient herpes simplex virus 1},
journal = {Immunology},
year = {2024},
doi = {10.1111/imm.13775}
}
EUVIMED